1. Dose Escalation Methods in Phase I Cancer Clinical Trials
2. Early phase clinical trials to identify optimal dosing and safety
3. Guideline on strategies to identify and mitigate risks for first‐in‐human and early clinical trials with investigational medicinal products.European Medicines Agency. EMEA/CHMP/SWP/28367/07 Rev. 1. Committee for Medicinal Products for Human Use (CHMP)2017.
4. Guidelines for Phase I clinical trials.Association of the British Pharmaceutical Industry (ABPI)2018.